Ultrasensitive quantitative digital ELISA for C. difficile toxins in stool
Description: The recent increase in global incidence and severity of disease caused by toxigenic Clostridium difficile presents a major clinical and diagnostic problem. Current methods for diagnosis of C. difficile infection have major limitations and improved diagnostics are urgently needed. We propose to develop a simple stool test that combines high analytical sensitivity with the clinical specificity of C. difficile toxin detection o allow us to optimally classify those with and without disease. Specifically, we propose to develop and clinically validate ultrasensitive and quantitative "digital ELISA" assays for C. difficile toxins A and B in stool specimens. This work will establish a solid technological foundation for future development of a low-cost, automated assay platform and for large prospective clinical studies to evaluate assay utility for predicting clinical outcome and monitoring therapeutic response.
Funding type: research
Funder scheme: R21
Start date: 2013-01-17
End date: 2014-12-31
Investigator: NIRA POLLOCK (lead)
Institution: Beth Israel Deaconess Medical Center
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Funded outputs count: 6
Funder award ID: R21AI103612
OpenAlex ID: G1929100743
